Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
3.850
-0.080 (-2.04%)
At close: Jul 26, 2024, 10:26 AM
3.810
-0.040 (-1.04%)
After-hours: Jul 26, 2024, 4:36 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $3.04 million as of July 26, 2024. Its market cap has decreased by -93.77% in one year.
Market Cap
3.04M
Enterprise Value
2.61M
1-Year Change
-93.77%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $411.31M to $3.04M, a decrease of -99.26%. That is a compound annual growth rate of -79.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.70M | -57.14% |
| Dec 29, 2023 | 6.30M | -88.44% |
| Dec 30, 2022 | 54.50M | -67.71% |
| Dec 31, 2021 | 168.80M | -58.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipella Pharmaceuticals | 3.16M |
| ZyVersa Therapeutics | 3.10M |
| Aptevo Therapeutics | 3.10M |
| INVO Bioscience | 3.09M |
| CNS Pharmaceuticals | 3.08M |
| Petros Pharmaceuticals | 2.94M |
| Qualigen Therapeutics | 2.79M |
| TC Biopharm (Holdings) | 2.72M |